ADMA Biologics Inc (ADMA)
6.905
+0.10
(+1.40%)
USD |
NASDAQ |
May 06, 16:00
6.905
0.00 (0.00%)
After-Hours: 18:28
ADMA Biologics Accounts Payable (Quarterly): 15.66M for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 15.66M |
September 30, 2023 | 10.85M |
June 30, 2023 | 12.08M |
March 31, 2023 | 12.96M |
December 31, 2022 | 13.23M |
September 30, 2022 | 25.20M |
June 30, 2022 | 11.39M |
March 31, 2022 | 14.12M |
December 31, 2021 | 12.43M |
September 30, 2021 | 17.28M |
June 30, 2021 | 6.168M |
March 31, 2021 | 12.15M |
December 31, 2020 | 11.07M |
September 30, 2020 | 7.980M |
June 30, 2020 | 6.910M |
March 31, 2020 | 9.152M |
December 31, 2019 | 9.175M |
September 30, 2019 | 8.960M |
June 30, 2019 | 6.788M |
March 31, 2019 | 5.480M |
December 31, 2018 | 5.900M |
September 30, 2018 | 5.268M |
June 30, 2018 | 3.101M |
March 31, 2018 | 5.718M |
Date | Value |
---|---|
December 31, 2017 | 5.921M |
September 30, 2017 | 9.156M |
June 30, 2017 | 4.672M |
March 31, 2017 | 3.904M |
December 31, 2016 | 2.565M |
September 30, 2016 | 2.777M |
June 30, 2016 | 3.317M |
March 31, 2016 | 2.468M |
December 31, 2015 | 2.088M |
September 30, 2015 | 2.185M |
June 30, 2015 | 1.648M |
March 31, 2015 | 1.779M |
December 31, 2014 | 1.779M |
September 30, 2014 | 2.445M |
June 30, 2014 | 2.340M |
March 31, 2014 | 2.764M |
December 31, 2013 | 2.710M |
September 30, 2013 | 1.483M |
June 30, 2013 | 1.159M |
March 31, 2013 | 1.379M |
December 31, 2012 | 1.059M |
September 30, 2012 | 0.8908M |
June 30, 2012 | 0.7909M |
March 31, 2012 | 0.5089M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
6.168M
Minimum
Jun 2021
25.20M
Maximum
Sep 2022
11.77M
Average
11.39M
Median
Jun 2022
Accounts Payable (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 7.145M |
ANI Pharmaceuticals Inc | 36.68M |
Ligand Pharmaceuticals Inc | 2.427M |
Johnson & Johnson | 8.174B |
Puma Biotechnology Inc | 6.889M |